New drug for Duchenne muscular dystrophy could help improve and prolong lives
Academics at Royal Holloway have developed a new genetic medicine that has been given the go ahead by the U.S Food and Drug Association (FDA) to be prescribed globally to a subset of patients with Duchenne muscular dystrophy ...
Feb 25, 2020
0
19